Abstract
On February 22, 2011, in the case of Bruesewitz v Wyeth ,1 the US Supreme Court preserved the crucial role of the National Childhood Vaccine Injury Act (NCVIA) in ensuring the continuing availability of children's vaccines in the United States. Although at first glance the Bruesewitz case may seem to be simply a technical decision that addressed the legal intricacies of products liability law, the case has important implications for pediatricians, their patients, and the continuity of our vaccine supply. By the 1980s, vaccines had become so successful at preventing many infectious diseases that the public was becoming much less alarmed by those diseases2 and much more concerned with the risk of injury from the vaccines themselves.3 As a result, the number of lawsuits alleging vaccine-related injuries exploded, driving manufacturers from the market and producing vaccine shortages. In 1986, the US Congress enacted … Address correspondence to Gary N. McAbee, DO, JD, Department of Neuroscience, New Jersey Neuroscience Institute, 65 James St, Edison, NJ 08818. E-mail: gmcabee{at}solarishs.org
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
